Monsanto's Roundup Herbicide Study Retracted Due to "Serious Ethical Concerns"
A scientific journal has formally retracted a 25-year-old study on the safety of Monsanto's popular herbicide Roundup, citing "serious ethical concerns" regarding the paper's authors and the company's influence over the research.
The study, published in 2000 by Gary Williams, Robert Kroes, and Ian Munro, concluded that glyphosate-based weed killers posed no health risks to humans. The findings were widely cited by regulators around the world, including the Environmental Protection Agency (EPA), as evidence of the safety of glyphosate herbicides.
However, internal company documents obtained in litigation brought by plaintiffs suffering from cancer have revealed Monsanto's significant influence over the study. Emails show that company officials praised the research paper and celebrated its publication, with one executive suggesting that ghostwriting another paper was a way to handle future research.
The retraction of the study is seen as a major victory for critics of the industry giant, who have long argued that Monsanto has used its financial muscle to manipulate scientific research. "This garbage ghostwritten study finally got the fate it deserved," said Brent Wisner, one of the lead lawyers in the Roundup litigation.
Journal Regulatory Toxicology and Pharmacology editor-in-chief Martin van den Berg stated that he took the step due to concerns about authorship, research findings, and potential conflicts of interest. The paper's conclusions were solely based on unpublished studies from Monsanto, ignoring other outside, published research.
Bayer AG, which acquired Monsanto in 2018, has defended the study, stating that its involvement was adequately noted in the acknowledgments section of the paper. However, critics argue that this does not address the broader issues of conflict of interest and manipulation of scientific research.
The retraction of the study is a significant blow to the credibility of Monsanto's claims about the safety of Roundup herbicides. The EPA has stated that it will continue to review glyphosate based on "gold standard science," but the agency will rely on studies other than the now-retracted paper.
As the Trump administration urged the US Supreme Court to curtail thousands of lawsuits claiming Roundup causes cancer, critics argue that this case highlights the ongoing struggle for scientific integrity and accountability in the face of corporate influence.
A scientific journal has formally retracted a 25-year-old study on the safety of Monsanto's popular herbicide Roundup, citing "serious ethical concerns" regarding the paper's authors and the company's influence over the research.
The study, published in 2000 by Gary Williams, Robert Kroes, and Ian Munro, concluded that glyphosate-based weed killers posed no health risks to humans. The findings were widely cited by regulators around the world, including the Environmental Protection Agency (EPA), as evidence of the safety of glyphosate herbicides.
However, internal company documents obtained in litigation brought by plaintiffs suffering from cancer have revealed Monsanto's significant influence over the study. Emails show that company officials praised the research paper and celebrated its publication, with one executive suggesting that ghostwriting another paper was a way to handle future research.
The retraction of the study is seen as a major victory for critics of the industry giant, who have long argued that Monsanto has used its financial muscle to manipulate scientific research. "This garbage ghostwritten study finally got the fate it deserved," said Brent Wisner, one of the lead lawyers in the Roundup litigation.
Journal Regulatory Toxicology and Pharmacology editor-in-chief Martin van den Berg stated that he took the step due to concerns about authorship, research findings, and potential conflicts of interest. The paper's conclusions were solely based on unpublished studies from Monsanto, ignoring other outside, published research.
Bayer AG, which acquired Monsanto in 2018, has defended the study, stating that its involvement was adequately noted in the acknowledgments section of the paper. However, critics argue that this does not address the broader issues of conflict of interest and manipulation of scientific research.
The retraction of the study is a significant blow to the credibility of Monsanto's claims about the safety of Roundup herbicides. The EPA has stated that it will continue to review glyphosate based on "gold standard science," but the agency will rely on studies other than the now-retracted paper.
As the Trump administration urged the US Supreme Court to curtail thousands of lawsuits claiming Roundup causes cancer, critics argue that this case highlights the ongoing struggle for scientific integrity and accountability in the face of corporate influence.